Insmed Inc. buy Wells Fargo & Company
Start price
03.09.25
/
50%
€124.00
Target price
03.09.26
€147.01
Performance (%)
-13.74%
Price
14.08.26
€106.68
Summary
This prediction is currently active. The prediction for Insmed Inc. disappoints with a performance of -13.74%. This prediction currently runs until 03.09.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 24.003% | 24.003% |
| iShares Core DAX® | 0,44 % | 5,90 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % |
| iShares S&P 500 | 0,37 % | 1,92 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed (NASDAQ:INSM) had its price target raised by analysts at Wells Fargo & Company from $140.00 to $171.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat